Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial
about
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial
description
im Oktober 2016 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 27 July 2016
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2016
@uk
name
Exenatide improves β-cell func ...... a randomised controlled trial
@en
Exenatide improves β-cell func ...... a randomised controlled trial
@nl
type
label
Exenatide improves β-cell func ...... a randomised controlled trial
@en
Exenatide improves β-cell func ...... a randomised controlled trial
@nl
prefLabel
Exenatide improves β-cell func ...... a randomised controlled trial
@en
Exenatide improves β-cell func ...... a randomised controlled trial
@nl
P2093
P50
P356
P1476
Exenatide improves β-cell func ...... a randomised controlled trial
@en
P2093
Andrea Mari
Anja Cornér
Daniël H van Raalte
HanneleYki-Järvinen
Marja-RiittaTaskinen
Mathijs C Bunck
Michaela Diamant
Robert J Heine
P304
P356
10.1530/EJE-16-0286
P577
2016-07-27T00:00:00Z